MedTrace Logo

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

NCT04955808 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2026-05-13

No results posted yet for this study

Summary

This research trial studies how well biospecimen collection works in identifying genetic changes in patients with breast, prostate, colorectal, liver, or kidney cancer or multiple myeloma undergoing surgery. Studying samples collected during surgery may add to the understanding of cancer by looking for the genetic changes that cause early cancer onset in people of certain racial and ethnic groups.

Conditions

  • Breast Carcinoma
  • Colon Carcinoma
  • Invasive Carcinoma
  • Kidney Carcinoma
  • Liver Carcinoma
  • Malignant Solid Neoplasm
  • Multiple Myeloma
  • Prostate Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of tissue and blood samples

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Michelle Bennett · National Cancer Institute Division of Cancer Prevention

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-07
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955808 on ClinicalTrials.gov